| ★ | BE HEARD EXT: Bimekizumab Shows Greater Benefit With Earlier Use in HS | | 14 | Estados Unidos | |
| 17 | Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata | | 611 | Estados Unidos | 85 |
| 5 | First Oral Therapy for #HidradenitisSuppurativa in Phase 3 | | 344 | Estados Unidos | 88 |
| 8 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 274 | Estados Unidos | 86 |
| 7 | How New Biologics Are Changing #AtopicDermatitis Treatment | | 272 | Estados Unidos | 86 |
| 4 | Results from the First Oral Phase 3 Therapy for #HidradenitisSuppurativa | | 210 | Estados Unidos | 88 |
| 3 | Why Povorcitinib's JAK1 Mechanism Matters for HS, With Martina Porter, MD | | 172 | Estados Unidos | 90 |
| 10 | How Are New Biologics Changing Atopic Dermatitis Treatment? | | 137 | Estados Unidos | 86 |
| 19 | How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD | | 109 | Estados Unidos | 85 |
| 9 | How Upadacitinib Could Expand Options for Severe Alopecia Areata, With Natasha Mesinkovska, MD, PhD | | 93 | Estados Unidos | 86 |
| 20 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 85 |
| 16 | What Upadacitinib Could Mean for Younger Patients With Severe Alopecia Areata | | 82 | Estados Unidos | 85 |
| 1 | Bimekizumab Data Support Case for Earlier Intervention in HS | | 78 | Estados Unidos | 96 |
| 12 | Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD | | 69 | Estados Unidos | 86 |
| 2 | STOP-HS: Povorcitinib Shows Durable Response in HS at Week 54 | | 60 | Estados Unidos | 90 |
| 13 | Can CSU Patients Achieve True Remission? BTK Inhibitors, Biomarker Barriers, & More | EAC 2026 | | 58 | Estados Unidos | 86 |
| 14 | Spotting Scarring Alopecia Before It's Too Late | | 42 | Estados Unidos | 85 |
| 11 | Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA | | 30 | Estados Unidos | 86 |
| 18 | Emerging Evidence in Atopic Dermatitis Management, With Harrison Nguyen, MD, MBA, MPH | | 23 | Estados Unidos | 85 |
| 6 | Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD | | 20 | Estados Unidos | 87 |
| 15 | Why Earlier Treatment Matters in Moderate-to-Severe Atopic Dermatitis | | 6 | Estados Unidos | 85 |